Diagnosis of CYP21A2 mutations typically involves a combination of biochemical tests and genetic testing. Biochemical tests measure hormone levels in the blood to detect enzyme deficiencies, while genetic testing can identify specific mutations in the CYP21A2 gene. Prenatal testing is also available for families with a known history of CAH.
